Latest News Headlines
|
"Apology Laws" May Reduce Litigation
Tuesday, December 02, 2008 - 09:10 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines Physicians are urged to learn their own states' version of "apology laws," which protect physicians if a malpractice suit results after they express sympathy to patients affected by medical errors. Reuters Health Information |
|
Should Physicians Avoid Interaction With the Drug Industry?
Tuesday, December 02, 2008 - 08:29 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines The relationship between doctors and pharmaceutical sales representatives is controversial. Who should regulate the amount of interaction between physicians and the drug industry? Medscape Internal Medicine |
|
McKesson settlement is next step in the demise of AWP
Monday, December 01, 2008 - 10:26 PM - 1 month ago - Newspaper & TV news - GLG News(sm): Healthcare McKesson Corp (MCK) settled its pending class action suit for $351 million and set aside a further $143 million reserve for certain future claims. The settlement removes a source of uncertainty for McKesson, but also signals the beginning of the end for the Average Wholesale Price (AWP) benchmark. Average Wholesale Price (AWP) data for pharmaceuticals is still being published, but will continue to lose appeal as a reimbursement benchmark for pharmacies and Pharmacy benefit managers (PBMs). |
|
Looks like price may still be the problem
Monday, December 01, 2008 - 04:48 PM - 1 month ago - Blog - Health Business Blog The current Health Affairs is devoted to The Price of Medical Technology. One section focuses on the Imaging Boom. The installed base of advanced imaging equipment (CT, MRI, PET, etc.) has risen rapidly and so, too have the number of procedures performed on them. That’s caused total spending to ramp up quickly, too. It seems logical to conclude that the free-market system in the US has led providers to boost the number of imaging machines and procedures. That may drive up costs but at least it ensures access that would be lacking in socialized systems, right? An article by Anderson and Frogner in the Data Watch section puts things in a somewhat different light. Their comparison of per capita health care spending in OECD countries shows, as usual, the US spending double the average, but this chart breaks the spending out by public private and out-of-pocket. Interestingly, per capita public (i.e., government) spending in the US is higher than every country but Luxemborg and Norway. Also, US public spending per capita is higher than median total spending in the OECD. For instance, US public spending per capita is higher than total per capita spending in the UK or Italy. None of this is that surprising. However, the following paragraph put the Imaging Boom articles in perspective. Our previous work has consistently shown that the United States has lower utilization rates than most other OECD countries (for example, numbers of hospital days and physician visits per capita). In addition, the supply of many medical services (hospital beds per capita) and expensive technologies such as magnetic resonance imaging (MRI) units and computed tomography (CT) scanners is lower in the United States than in many other OECD countries (Exhibit 2). In each of these papers, we have returned to the conclusion that much of the spending differences are attributable to the higher per capita income of the United States and the fact that Americans pay much higher prices for medical care services (”It’s the Prices, Stupid”). In other words, it may indeed be a serious problem that CT and MRI use is rising relentlessly in the US. However it doesn’t mean that such technologies are any less available elsewhere. Perhaps deflation –already taking root in other parts of the economy– is the simple cure for US health care costs. 48ac |
|
UN Warns Against Cuts to AIDS Prevention Programmes
Monday, December 01, 2008 - 01:07 PM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines HIV infections could surge if countries pinched by the global financial crisis cut AIDS prevention programmes, a United Nations agency said on Friday. Reuters Health Information |
|
EU Says Raids on Drugmakers Continue on Wednesday
Monday, December 01, 2008 - 09:42 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines The European Commission said it was continuing on Wednesday raids it had carried out on a number of pharmaceutical companies across the European Union on suspicion they were pursuing restrictive practices. Reuters Health Information |
|
New York Times Looks Back at Minimal Impact of Massive ALLHAT Trial
Monday, December 01, 2008 - 09:23 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines Six years after the 44 000-patient trial was reported, use of generic diuretics never reached the levels that investigators expected. Reasons include patents ending, new drugs emerging, the advent of combination pills, but also the millions of dollars spent by companies making brand-name antihypertensives. Medscape Medical News |
|
Medical Home: Nurse Practitioners' Role in Health Care Delivery to Vulnerable Populations
Monday, December 01, 2008 - 09:11 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines Learn about the concept of medical home, the role of NPs, and the current legislation addressing this issue. Journal of Pediatric Health Care |
|
Prescriptions for Survival
Monday, December 01, 2008 - 06:50 AM - 1 month ago - Newspaper & TV news - Medscape Business of Medicine Headlines Nancy Covington, BSc, MD, President of Physicians for Global Survival, Halifax, Nova Scotia, Canada, invites us to reconnect with the physicians' movement against nuclear war. The Medscape Journal of Medicine |
|
Sales of Infuse product will likely decline with closer scrutiny of off-label use
Monday, December 01, 2008 - 05:24 AM - 1 month ago - Newspaper & TV news - GLG News(sm): Healthcare Medtronic might see a significant drop in its sales as a result of closer scrutiny of off-label use of its products. Infuse has been a cash cow for Medtronic, and if sales drop, it will reflect deeply in the sales numbers. |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 29 – 39 – 49 – 59 – 69 – 79 – 89 >
There are 1 unlogged user and 0 registered users online.
You can log-in or register for a user account here.
You can log-in or register for a user account here.
Preferred language:
